Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Feil Family Brain & Mind Research Institute
Explore this Website
Home
About BMRI
Toggle About BMRI menu options
Our Mission
Research Programs
Training
Facilities
Campus
Ways to Give
Administration
Faculty
Toggle Faculty menu options
Faculty, Primary Appointments
Faculty, Secondary Appointments
Affiliate Faculty
Research
Toggle Research menu options
Appel Institute
Center for Neurogenetics
Clinical & Translational Neuroscience Unit
Toggle Clinical & Translational Neuroscience Unit menu options
CTNU Director
CTNU Research Opportunities
Affiliate Institutions
New Grants
Publications
News
Toggle News menu options
Faculty Spotlight and Awards
New Grants
Events
Education
Toggle Education menu options
Neuroscience Graduate Program
Neuroscience Retreat
Leon Levy Fellowship
Research Residency
Brain Awareness
Medical School AOC
First Year Students
Core Facilities
Toggle Core Facilities menu options
Neuroanatomy EM Core
Neurogenetic Repository
BMRI Cores
Diversity and Inclusion
Toggle Diversity and Inclusion menu options
BMRI Diversity and Inclusion
Emerging Leaders in Neuroscience
BMRI Summer Scholars Program
Weill Cornell Medicine
Care
Discover
Teach
Home
About BMRI
Faculty
Research
News
Events
Education
Core Facilities
Diversity and Inclusion
Home
Publications
Publications
Appel Institute
Center for Neurogenetics
Clinical & Translational Neuroscience Unit
Affiliate Institutions
New Grants
Publications
Publications
Found 18 results
Author
[
Title
]
Type
Year
Filters:
Author
is
Vartanian, Timothy
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Ranganathan U
,
Kaunzner U
,
Foster S
,
Vartanian T
,
Perumal JS
. 2018.
Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.
.
Mult Scler. 24(4):553-554.
S
Kaunzner UW
,
Kumar G
,
Askin G
,
Gauthier SA
,
Nealon NN
,
Vartanian T
,
Perumal JS
. 2016.
A study of patients with aggressive multiple sclerosis at disease onset.
.
Neuropsychiatr Dis Treat. 12:1907-12.
R
Goodin DS
,
Reder AT
,
Bermel RA
,
Cutter GR
,
Fox RJ
,
John GR
,
Lublin FD
,
Lucchinetti CF
,
Miller AE
,
Pelletier D
et al.
. 2016.
Relapses in multiple sclerosis: Relationship to disability.
.
Mult Scler Relat Disord. 6:10-20.
Bennett JL
,
Nickerson M
,
Costello F
,
Sergott RC
,
Calkwood JC
,
Galetta SL
,
Balcer LJ
,
Markowitz CE
,
Vartanian T
,
Morrow M
et al.
. 2015.
Re-evaluating the treatment of acute optic neuritis.
.
J Neurol Neurosurg Psychiatry. 86(7):799-808.
Kaunzner UW
,
Kang Y
,
Monohan E
,
Kothari PJ
,
Nealon N
,
Perumal J
,
Vartanian T
,
Kuceyeski A
,
Vallabhajosula S
,
P Mozley D
et al.
. 2017.
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
.
Mult Scler Relat Disord. 15:27-33.
N
Telesford KM
,
Smith C
,
Mettlen M
,
Davis MB
,
Cowell L
,
Kittles R
,
Vartanian T
,
Monson N
. 2023.
Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment.
.
Brain Commun. 5(4):fcad218.
M
Rumah KRashid
,
Ma Y
,
Linden JR
,
Oo MLin
,
Anrather J
,
Schaeren-Wiemers N
,
Alonso MA
,
Fischetti VA
,
McClain MS
,
Vartanian T
. 2015.
The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.
.
PLoS Pathog. 11(5):e1004896.
Vargas WS
,
Monohan E
,
Pandya S
,
Raj A
,
Vartanian T
,
Nguyen TD
,
Rúa SMHurtado
,
Gauthier SA
. 2015.
Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.
.
Neuroimage Clin. 9:369-75.
I
Kocsik AS
,
Klein DE
,
Liedke M
,
Kaunzner UW
,
Nealon NM
,
Gauthier SA
,
Vartanian T
,
Perumal JS
. 2018.
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.
.
J Neurol. 265(5):1226-1229.
Pandya S
,
Kaunzner UW
,
Rúa SMHurtado
,
Nealon N
,
Perumal J
,
Vartanian T
,
Nguyen TD
,
Gauthier SA
. 2020.
Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.
.
J Neuroimaging. 30(4):537-543.
Ranganathan U
,
Kaunzner U
,
Foster S
,
Vartanian T
,
Perumal JS
. 2018.
Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.
.
Mult Scler. 24(4):540-542.
E
Ma Y
,
Sannino D
,
Linden JR
,
Haigh S
,
Zhao B
,
Grigg JB
,
Zumbo P
,
Dündar F
,
Butler DJ
,
Profaci CP
et al.
. 2023.
Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege.
.
J Clin Invest.
D
Al-Kawaz M
,
Monohan E
,
Morris E
,
Perumal JS
,
Nealon N
,
Vartanian T
,
Gauthier SA
. 2017.
Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.
.
J Neuroimaging. 27(3):333-338.
Williams MJ
,
Okai AF
,
Cross AH
,
Monson NL
,
Vartanian T
,
Thrower BW
,
Reder AT
,
English JB
,
Wu GF
,
Bernitsas E
et al.
. 2023.
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.
.
Mult Scler Relat Disord. 76:104794.
C
Linden JR
,
Flores C
,
Schmidt EF
,
Uzal FA
,
Michel AO
,
Valenzuela M
,
Dobrow S
,
Vartanian T
. 2019.
Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.
.
PLoS Pathog. 15(11):e1008014.
Linden JR
,
Ma Y
,
Zhao B
,
Harris JMichael
,
Rumah KRashid
,
Schaeren-Wiemers N
,
Vartanian T
. 2015.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
.
MBio. 6(3):e02513.
Shetty SV
,
Mazzucco MR
,
Winokur P
,
Haigh SV
,
Rumah KRashid
,
Fischetti VA
,
Vartanian T
,
Linden JR
. 2023.
Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.
.
Toxins (Basel). 15(7)
B
Telesford KM
,
Kaunzner UW
,
Perumal J
,
Gauthier SA
,
Wu X
,
Díaz I
,
Kruse-Hoyer M
,
Engel C
,
Marcille M
,
Vartanian T
. 2020.
Black African and Latino/a identity correlates with increased plasmablasts in MS.
.
Neurol Neuroimmunol Neuroinflamm. 7(1)